Library

Protected: One-Pager for Government Officials

Client: Gilead Sciences, Government and Public Policy
BKW Team: Adrian Bonifacio
Audience: Local, State and National US Government Officials
About: Remdesivir is Gilead’s treatment for patients with severe COVID-19

Locked Content

To view this protected post, please enter the password below.
Don't have a password? Click here to request one.

©2023 BKW Partners  |  Privacy 

San Francisco based. Working globally.    |   hi@bkw.io

Instagram

Are you on the list?

We send short-short takes on marketing, communications, growth, tech, design, branding, and creativity — all the things we work on at BKW for our tech and healthcare clients.  

Our mails are read by the good people at Google, Gilead, BMW, Fedex, and many (many) more. 

Think Learn Laugh Grow Get inspired with BKW

Short-short takes on marketing, communications, growth, tech, design, branding, and creativity — all the things we work on at BKW for our tech and healthcare clients.

Best comments win.

Get the freshest posts delivered to your inbox every week. You’ll be in good company, our blog is read by the good people at Google, Gilead, BMW, Fedex, and many (many) more.